This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (33)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Ravi Dhingra, MD; Lisa M. Sullivan, PhD; Caroline S. Fox, MD; Thomas J. Wang, MD; Ralph B. D’Agostino Sr, PhD; J. Michael Gaziano, MD, MPH; Ramachandran S. Vasan, MD

Arch Intern Med. 2007;167(9):879-885.

Background  Higher levels of serum phosphorus and the calcium-phosphorus product are associated with increased mortality from cardiovascular disease (CVD) in patients with chronic kidney disease (CKD) or prior CVD. However, it is unknown if serum phosphorus levels influence vascular risk in individuals without CKD or CVD.

Methods  We prospectively evaluated 3368 Framingham Offspring study participants (mean age, 44 years; 51% were women) free of CVD and CKD. We used multivariable Cox models to relate serum phosphorus and calcium levels to CVD incidence.

Results  On follow-up (mean duration, 16.1 years), there were 524 incident CVD events (159 in women). In multivariable analyses and adjusting for established risk factors and additionally for glomerular filtration rate and for hemoglobin, serum albumin, proteinuria, and C-reactive protein levels, a higher level of serum phosphorus was associated with an increased CVD risk in a continuous fashion (adjusted hazard ratio per increment of milligrams per deciliter, 1.31; 95% confidence interval, 1.05-1.63; P = .02; P value for trend across quartiles = .004). Individuals in the highest serum phosphorus quartile experienced a multivariable-adjusted 1.55-fold CVD risk (95% confidence interval, 1.16%-2.07%; P = .004) compared with those in the lowest quartile. These findings remained robust in time-dependent models that updated CVD risk factors every 4 years and in analyses restricted to individuals without proteinuria and an estimated glomerular filtration rate greater than 90 mL/min per 1.73 m². Serum calcium was not related to CVD risk.

Conclusion  Higher serum phosphorus levels are associated with an increased CVD risk in individuals free of CKD and CVD in the community. These observations emphasize the need for additional research to elucidate the potential link between phosphorus homeostasis and vascular risk.

Author Affiliations: National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Mass (Drs Dhingra, Fox, Wang, D’Agostino, and Vasan); Massachusetts Veterans Epidemiology Research and Information Center, Veterans Administration Boston Healthcare System (Drs Dhingra and Gaziano), and Division of Aging, Brigham and Women's Hospital (Drs Dhingra and Gaziano), Boston; Department of Medicine, Alice Peck Day Memorial Hospital, Lebanon, NH (Dr Dhingra); Division of Cardiology, Massachusetts General Hospital, Boston (Dr Wang); Department of Biostatistics, School of Public Health (Drs Sullivan and D’Agostino), and Cardiology Section and Department of Preventive Medicine and Epidemiology, School of Medicine (Dr Vasan), Boston University, Boston; and National Heart, Lung and Blood Institute, Bethesda, Md (Dr Fox).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTER

Phosphorus-Related Mechanisms of Vascular Calcification
Vincenzo Savica, Guido Bellinghieri, and Domenico Santoro
Arch Intern Med. 2007;167(21):2368.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Phosphorus Comes of Age as a Cardiovascular Risk Factor
Robert N. Foley
Arch Intern Med. 2007;167(9):873-874.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Glomerular filtration rate and serum phosphate: an inverse relationship diluted by age
Cirillo et al.
Nephrol Dial Transplant 2009;24:2123-2131.
ABSTRACT | FULL TEXT  

Dietary Phosphorus Acutely Impairs Endothelial Function
Shuto et al.
J. Am. Soc. Nephrol. 2009;20:1504-1512.
ABSTRACT | FULL TEXT  

Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
Hagstrom et al.
Circulation 2009;119:2765-2771.
ABSTRACT | FULL TEXT  

Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients
Chiu et al.
CJASN 2009;4:1089-1096.
ABSTRACT | FULL TEXT  

Phosphate Levels and Cardiovascular Disease in the General Population
Foley
CJASN 2009;4:1136-1139.
ABSTRACT | FULL TEXT  

Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults
Anderson et al.
J. Am. Soc. Nephrol. 2009;20:1199-1209.
ABSTRACT | FULL TEXT  

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
Covic et al.
Nephrol Dial Transplant 2009;24:1506-1523.
ABSTRACT | FULL TEXT  

Serum Phosphorus Concentrations and Arterial Stiffness among Individuals with Normal Kidney Function to Moderate Kidney Disease in MESA
Ix et al.
CJASN 2009;4:609-615.
ABSTRACT | FULL TEXT  

Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease: A Randomized Controlled Trial
Sullivan et al.
JAMA 2009;301:629-635.
ABSTRACT | FULL TEXT  

Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults
Foley et al.
J. Am. Soc. Nephrol. 2009;20:397-404.
ABSTRACT | FULL TEXT  

Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD
Adeney et al.
J. Am. Soc. Nephrol. 2009;20:381-387.
FULL TEXT  

Phosphorus Binders and Survival on Hemodialysis
Isakova et al.
J. Am. Soc. Nephrol. 2009;20:388-396.
ABSTRACT | FULL TEXT  

Associations and consequences of hypophosphataemia in older hospitalised women
Sumukadas et al.
Age Ageing 2009;38:112-115.
FULL TEXT  

Investigation of Gender Heterogeneity in the Associations of Serum Phosphorus With Incident Coronary Artery Disease and All-Cause Mortality
Onufrak et al.
Am J Epidemiol 2009;169:67-77.
ABSTRACT | FULL TEXT  

Crystal Structure of Filamentous Aggregates of Human DJ-1 Formed in an Inorganic Phosphate-dependent Manner
Cha et al.
J. Biol. Chem. 2008;283:34069-34075.
ABSTRACT | FULL TEXT  

Accelerated Atherosclerotic Calcification and Monckeberg's Sclerosis: A Continuum of Advanced Vascular Pathology in Chronic Kidney Disease
McCullough et al.
CJASN 2008;3:1585-1598.
ABSTRACT | FULL TEXT  

The bone-renal axis in early chronic kidney disease: an emerging paradigm
Danziger
Nephrol Dial Transplant 2008;23:2733-2737.
FULL TEXT  

25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
Melamed et al.
Arch Intern Med 2008;168:1629-1637.
ABSTRACT | FULL TEXT  

Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004
Melamed et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1179-1185.
ABSTRACT | FULL TEXT  

Phosphorus-Related Mechanisms of Vascular Calcification
Savica et al.
Arch Intern Med 2007;167:2368-2368.
FULL TEXT  

Dietary vitamin D and decreases in cancer rates: Canada as the national experiment
Sood and Sood
Am. J. Clin. Nutr. 2007;86:1549-1549.
FULL TEXT  

Phosphorus Comes of Age as a Cardiovascular Risk Factor
Foley
Arch Intern Med 2007;167:873-874.
FULL TEXT